-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.15-47.17% Downside
Clover Health Investments, Corp. Frequently Asked Questions
-
What analysts cover Clover Health Investments, Corp.?
Clover Health Investments, Corp. has been rated by research analysts at Canaccord Genuity, Citigroup in the past 90 days.